|
|
||||||||
-Chain of Cytokine Receptors Induces T Cell Apoptosis and Long-Term Islet Allograft Survival1

*
Department of Medicine, Division of Immunology, Harvard Medical School, Beth Israel Deaconess Medical Center, Boston, MA 02215; and
Department of Microbiology and Immunology, University of Miami, Miami, FL 33101
The common
c-chain is an essential signaling component shared by
all known T cell growth factor (TCGF) receptors (i.e., IL-2, IL-4,
IL-7, IL-9, and IL-15). In the present study, we have studied the
effect of
c-chain blockade on T cell activation and allograft
rejection. Treatment of B6AF1 (H-2b/d.k)
recipient mice with anti-
c mAbs induced long-term survival of
DBA/2 (H-2d) islet allografts (>150 days,
n = 8), whereas control Ab-treated mice rejected
the islet allografts within 17 days (n = 6). The
state of engraftment induced by the anti-
c mAbs was remarkably
stable, as recipient mice bearing the primary islet allografts accepted
a second DBA/2 islet allograft without further immunosuppression and
systemic administration of high doses of IL-2Ig fusion protein failed
to provoke rejection. Blocking the
c-chain inhibited T cell
proliferation and induced T cell apoptosis by repressing expression of
Bcl-2. Our data suggest that one means of inducing T cell apoptosis and
stable allograft survival can be achieved via
c-chain
blockade.
This article has been cited by other articles:
![]() |
A. Plesner, P. Liston, R. Tan, R. G. Korneluk, and C. B. Verchere The X-Linked Inhibitor of Apoptosis Protein Enhances Survival of Murine Islet Allografts Diabetes, September 1, 2005; 54(9): 2533 - 2540. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. D. Vu, F. Amanullah, Y. Li, G. Demirci, M. H. Sayegh, and X. C. Li Different Costimulatory and Growth Factor Requirements for CD4+ and CD8+ T Cell-Mediated Rejection J. Immunol., July 1, 2004; 173(1): 214 - 221. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. Demirci, T. B. Strom, and X. C. Li Islet Allograft Rejection in Nonobese Diabetic Mice Involves the Common {gamma}-Chain and CD28/CD154-Dependent and -Independent Mechanisms J. Immunol., October 1, 2003; 171(7): 3878 - 3885. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. AKDIS, A. TRAUTMANN, S. KLUNKER, I. DAIGLE, U. C. KUCUKSEZER, W. DEGLMANN, R. DISCH, K. BLASER, and C. A. AKDIS T helper (Th) 2 predominance in atopic diseases is due to preferential apoptosis of circulating memory/effector Th1 cells FASEB J, June 1, 2003; 17(9): 1026 - 1035. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. Demirci, W. Gao, X. X. Zheng, T. R. Malek, T. B. Strom, and X. C. Li On CD28/CD40 Ligand Costimulation, Common {gamma}-Chain Signals, and the Alloimmune Response J. Immunol., May 1, 2002; 168(9): 4382 - 4390. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Rabinovitch, W. L. Suarez-Pinzon, A.M. J. Shapiro, R. V. Rajotte, and R. Power Combination Therapy With Sirolimus and Interleukin-2 Prevents Spontaneous and Recurrent Autoimmune Diabetes in NOD Mice Diabetes, March 1, 2002; 51(3): 638 - 645. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. R. Jones, J. Ha, M. A. Williams, A. B. Adams, M. M. Durham, P. A. Rees, S. R. Cowan, T. C. Pearson, and C. P. Larsen The Role of the IL-2 Pathway in Costimulation Blockade-Resistant Rejection of Allografts J. Immunol., February 1, 2002; 168(3): 1123 - 1130. [Abstract] [Full Text] [PDF] |
||||
![]() |
F. Behbod, R. A. Erwin-Cohen, M.-E. Wang, B. W. Trawick, X. Qu, R. Verani, B. D. Kahan, S. M. Stepkowski, and R. A. Kirken Concomitant Inhibition of Janus Kinase 3 and Calcineurin-Dependent Signaling Pathways Synergistically Prolongs the Survival of Rat Heart Allografts J. Immunol., March 15, 2001; 166(6): 3724 - 3732. [Abstract] [Full Text] [PDF] |
||||
![]() |
X. G. Smith, E. M. Bolton, H. Ruchatz, X.-q. Wei, F. Y. Liew, and J. A. Bradley Selective Blockade of IL-15 by Soluble IL-15 Receptor {alpha}-Chain Enhances Cardiac Allograft Survival J. Immunol., September 15, 2000; 165(6): 3444 - 3450. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |